4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • GLOW: Phase III study of first-line zolbetuximab + CAPOX versus placebo + CAPOX in Claudin18.2(+)/HER2(-) advanced/metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)
    Meeting Abstract

    Xu, R. H.; Ajani, J. A.; Al-Batran, S. E.; Bang, Y. J.; Catenacci, D.; Enzinger, P. C.; Ilson, D. H.; Kim, S.; Lordick, F.; Shitara, K.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab vs chemotherapy in patients with microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: Asia subgroup results of the phase III KEYNOTE-177 study
    Meeting Abstract

    Yoshino, T.; Kim, T. W.; Yong, W. P.; Shiu, K. K.; Vittrup Jensen, B.; Henrik Jensen, L; Smith, D.; Garcia-Carbonero, R.; Alcaide-Garcia, J.; Gibbs, P.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • A randomized, double-blind, phase III study of pembrolizumab plus chemotherapy as first-line therapy in patients with HER2-negative, advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: KEYNOTE-859
    Meeting Abstract

    Qin, S.; Tabernero, J.; van Cutsem, E.; Fuchs, C. S.; Janjigian, Y. Y.; Bhagia, P.; Li, K.; Adelberg, D.; Bang, Y. J.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Management of adverse events associated with encorafenib plus cetuximab in patients with BRAF V600E mutant metastatic colorectal cancer (BEACON CRC Study)
    Meeting Abstract

    Chiu, C. F.; Yeh, Y. M.; Yeh, K. H.; Desai, J.; Price, T. J.; Tebbutt, N.; Tabernero, J.; Velez, L.; Trevino, T. L.; Grothey, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline
    Guidelines

    Gordan, J. D.; Kennedy, E. B.; Abou-Alfa, G. K.; Beg, M. S.; Brower, S. T.; Gade, T. P.; Goff, L.; Gupta, S.; Guy, J.; Harris, W. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade
    Journal Article

    Zhang, Q.; Luo, J.; Wu, S.; Si, H.; Gao, C.; Xu, W.; Abdullah, S. E.; Higgs, B. W.; Dennis, P. A.; van der Heijden, M. S.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Cell-free DNA (cfDNA) and exosome profiling from a year-long human spaceflight reveals circulating biomarkers
    Journal Article

    Bezdan, D.; Grigorev, K.; Meydan, C.; Pelissier Vatter, F. A.; Cioffi, M.; Rao, V.; MacKay, M.; Nakahira, K.; Burnham, P.; Afshinnekoo, E.; more...
    iScience (2020)

    Fulltext@MSK | Save
  • Phase II multicenter, open-label study of oral ENMD-2076 for the treatment of patients with advanced fibrolamellar carcinoma
    Journal Article

    Abou-Alfa, G. K.; Mayer, R.; Venook, A. P.; O'Neill, A. F.; Beg, M. S.; LaQuaglia, M.; Kingham, P. T.; Kobos, R.; Basturk, O.; Brennan, C.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Phase Ib study of enzalutamide with or without sorafenib in patients with advanced hepatocellular carcinoma
    Journal Article

    Harding, J. J.; Kelley, R. K.; Tan, B.; Capanu, M.; Do, G. K.; Shia, J.; Chou, J. F.; Ferrer, C. S.; Boussayoud, C.; Muenkel, K.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Insertion of an Alu-like element in MLH1 intron 7 as a novel cause of Lynch syndrome
    Journal Article

    Li, Y.; Salo-Mullen, E.; Varghese, A.; Trottier, M.; Stadler, Z. K.; Zhang, L.
    Molecular Genetics and Genomic Medicine (2020)

    Fulltext@MSK | Save